FOR IMMEDIATE RELEASE
MESA, Ariz. — December 12, 2024
The Marchand Institute’s newest paper, “Efficacy of conservative laparoscopic surgical treatment for acute ovarian torsion in pediatrics and adolescent populations: A single-armed meta-analysis” is now available online! You can view this exciting analysis on the original journal website here:
Or on the NIH’s Pubmed Website here:
https://pubmed.ncbi.nlm.nih.gov/39663806
Dr. Marchand and the Marchand Institute look forward to your feedback on our latest work!
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###